Live date: Thursday 18 October. This webinar talks about the benefit of incorporating microsampling techniques in bioanalytical assays, as well as the effort required to overcome the challenges.
Available to view on demand. Accurate and precise biomarker measurement is critical to identifying diagnostic markers and druggable targets. Learn how quantitative mass spectrometry ensures proper biomarker measurement and characterization.
Live date: Thursday 11 October 2018. Join our webinar to learn about the critical parameters related to the development of cell-based assays, the expected challenges and how binding assays could potentially be an acceptable replacement.
Available to view on demand. In this panel discussion, we hear from key experts in the field about their research and expertise, how they overcome key challenges associated with the technologies they work with and what they envision for the future of biomarker research and validation.
Available to view on demand. Selection and validation of biomarkers can be the difference between the success and failure of a pharmaceutical or biopharmaceutical drug development program.
Available to view on demand. Challenged to remove matrix interferences while dealing with the evolving complexity of biotherapeutics? This presentation illustrates how SelexION+ DMS can be efficiently utilized to overcome background interference challenges, which might otherwise limit assay capabilities.
Available to view on demand. We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on new technology integration in the field of bioanalysis.
Available to view on demand. Single molecule counting (SMC™) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/mL levels, allowing researchers to identify new biomarkers or assist in therapeutic development with an improved view of efficacy, safety and time course studies. Find out more in this video webinar from Millipore Sigma (MA, USA).
Available to view on demand.
In this free panel discussion, our experts will provide insights into their own research with large molecules including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field. There is also an opportunity for your own questions to be answered in the live Q&A.
Learn about new UHPLC column technologies and how to exploit them for improved characterization of biomacromolecules in our free upcoming webinar!
Researchers from Scripps Research (CA, USA) have recently released a new technology platform designed to allow scientists to more easily quantify molecules from biological samples and make their results public.
A team from the UC Davis MIND Institute and NeuroPointDX (CA, USA) have developed a metabolic blood test that could identify approximately 17% of children with autism spectrum disorder (ASD).
In this editorial Yu Shrike Zhang (Harvard Medical School; MA, USA), a previous finalist of the Bioanalysis Rising Star Award, discusses his research and hopes for the future. He details the emergence of organ-on-a-chip systems and how these platforms reproduce tissue functions outside the human body.
In this interview, Anita Tailor (Merck) discusses biomarker validation and standardization before predicting what the future may hold for biomarker research.